Shimin Sun, M.D., MPH

Mar 31, 2021View PDF

Ms. Sun has nearly 20 years of clinical development and clinical trial operations experience in different disease areas, especially in oncology and infectious diseases. She participated, managed and led over 70 clinical trials across Phase I to Phase IV.

Ms. Sun was involved in many important China registration projects, including HERCEPTIN®, PEGASYS®, PEGINTRON®, TARCEVA® and the first rituximab biosimilar product in China.